NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OcuCell Inc.

OcuCell Inc.

Private
Portland, OregonHealthcare & Life Scienceshttps://www.ocucell.bio/

Last Round

Seed

Sep 26, 2023

Company Overview

OcuCell Inc. is a biotechnology company that develops regenerative cell therapies for the treatment of corneal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

regenerative cell therapycorneal graftscell therapytissue engineeringregenerative medicinecorneal diseaselimbal stem cell deficiencyLSCDvision restorationophthalmic therapeuticsendothelial diseaseEndo-Tektherapeutic graftslab-grown tissue

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OcuCell Inc. Comps

Public and private peers based on sector, stage, and business model.

OcuCell Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OcuCell Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 26, 2023

OcuCell Inc. Investors

Notable investors and investment history

OcuCell Inc. investors
InvestorRounds
Johns Hopkins Technology VenturesSeed
Eye Bank Association of AmericaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 26, 2023

    Secured seed funding from multiple investors including Johns Hopkins Technology Ventures.

OcuCell Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OcuCell Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OcuCell Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPortland, Oregon
Year Founded2022
Last FundingSep 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.